Alport Syndrome
📧 Sign up to get email alerts when something new happens for Alport Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT) [Phase 4]
Phase 4 trial evaluating whether dapagliflozin, spironolactone, or their combination lowers albuminuria in adults with Alport syndrome and r…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: ASF Alport Patient Registry
The Alport Syndrome Foundation-sponsored clinical trial is updating on the ASF Alport Patient Registry, which is currently recruiting to col…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Evaluate Setanaxib in Patients With Alport Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating setanaxib in patients with Alport syndrome has completed and posted results.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety [Phase 2]
Phase 2 EXACT study evaluating Exaluren for Alport syndrome (X-linked and autosomal recessive) is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: BAY3401016; Biomarker Study Alport [Phase 2]
A Phase 2 biomarker study of BAY3401016 for Alport syndrome is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Study of ELX-02 in Patients With Alport Syndrome [Phase 2]
A Phase 2 study evaluating ELX-02 in patients with Alport Syndrome has completed and results have been posted.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: NEPTUNE Match Study [NA]
The NEPTUNE Match Study is currently recruiting, focusing on nephrotic syndrome in children and related glomerular diseases such as focal se…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1) [Phase 2]
A Phase 2 trial (ALPESTRIA-1) evaluated the safety and efficacy of vonafexor for Alport Syndrome and has completed.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases [Phase 2]
Travere Therapeutics is running a phase 2 pediatric trial of sparsentan for proteinuric glomerular diseases, including Focal Segmental Glome…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Alport Syndrome Treatments and Outcomes Registry
The University of Minnesota completed the Alport Syndrome Treatments and Outcomes Registry, a clinical trial registry tracking treatments an…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 study evaluating R3R01 in patients with Alport syndrome and focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)
This entry provides information about the RaDiCo Eurbio-Alport study, a RaDiCo cohort investigation sponsored by INSERM, which is currently …
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Atrasentan in Patients With Proteinuric Glomerular Diseases [Phase 2]
Phase 2 trial of atrasentan for proteinuric glomerular diseases is active but not recruiting, including IgA nephropathy, Focal segmental glo…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
The Alport Therapy Registry is a European research initiative to delay renal failure in Alport syndrome and is currently recruiting particip…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome [Phase 2, Phase 3]
The document describes an ongoing Phase 2/Phase 3 clinical trial evaluating human umbilical cord mesenchymal stem cells for Alport syndrome,…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Effects of Dapagliflozin on Progression of Alport Syndrome
Clinical trial update on the effects of dapagliflozin for progression of Alport syndrome; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) [Phase 3]
The Phase 3 extended access program for bardoxolone methyl in chronic kidney disease was terminated, with results posted in March 2024. The …
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study of Lademirsen (SAR339375) in Patients With Alport Syndrome [Phase 2]
This is a Phase 2 clinical trial update for Lademirsen (SAR339375) in Alport syndrome. The study has been terminated and results have been p…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL [Phase 2, Phase 3]
A Phase 2/3 trial (CARDINAL) evaluating Bardoxolone methyl for Alport syndrome has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome [Phase 2]
Phase 2 clinical trial evaluating intensified treatment with ACE inhibitors, AT1 receptor blockers, and statins for Alport Syndrome has comp…
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Treatment With Metformin in Chinese Children With Alport Syndrome [Phase 4]
Phase 4 clinical trial evaluating metformin in Chinese children with Alport syndrome.
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome [Phase 3]
Phase 3 trial update evaluating efficacy and safety to delay renal failure in children with Alport syndrome.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
This ClinicalTrials.gov update reports on a prospective study assessing microalbuminuria in untreated boys with Alport syndrome; the trial i…
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study
A multi-center feasibility study investigating Alport Syndrome has completed.
-
CLINICAL_TRIALS withdrawal · 2014-02-11Clinical Trial Update: Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
A Novartis-sponsored clinical trial studying urine biomarkers for Alport syndrome has terminated, marking the withdrawal of the trial.